1. 10P Deep learning-based prediction of patient's TLS status from HE images in pan-cancer cohort. (December 2022) Authors: Vanhersecke, L.; Gillet, L.; Le Douget, J-E.; Schmauch, B.; Maussion, C.; Italiano, A.; Soubeyran, I.; Le Loarer, F. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1496PEORTC experience with advanced/metastatic epithelioid sarcoma patients treated in prospective trials: Clinical profile and response to systemic therapy. (18th September 2017) Authors: Touati, N.; Schoffski, P.; Litière, S.; Judson, I.; Sleijfer, S.; van der Graaf, W.T.A.; Italiano, A.; Isambert, N.; Gil, T.; Blay, J-Y.; Stark, D.; Brodowicz, T.; Marreaud, S.; Gronchi, A. Journal: Annals of oncology Issue: Volume 28(2017)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 176P Phase I study of INCB106385 alone or in combination with immunotherapy in advanced solid tumors. (December 2022) Authors: Italiano, A.; Saavedra Santa Gadea, O.; Papadopoulos, K.; Naing, A.; Gomez-Roca, C.A.; Mita, M.; Stein, M.; Rybicka, I.; van der Velden, M.; Zhang, P.; Smith, M.; Ivanova, O.; Loriot, Y. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 188P IPH5201 as monotherapy or in combination with durvalumab (D) in advanced solid tumours. (December 2022) Authors: Imbimbo, M.; Hollebecque, A.; Italiano, A.; McKean, M.; Macarulla, T.; Castanon Alvarez, E.; Carneiro, B.A.; Mager, R.; Barnhart, V.; Murtomaki, E.; He, Y.; Cooper, Z.A.; Tu, E.; Linke, A.; Fan, C.; Zhou, D.; Boyer Chammard, A.; Paturel, C.L.; Fraenkel, P.G.; Powderly, J. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 302 A phase 1 study of EPZ-6438 (E7438), an Enhancer of Zeste-Homolog 2 (EZH2) inhibitor: Preliminary activity in INI1-negative tumors. (September 2015) Authors: Italiano, A.; Keilhack, H.; Toulmonde, M.; Coindre, J.M.; Michot, J.M.; Massard, C.; Ottesen, L.; Reyderman, L.; Blakemore, S.J.; Kraljevic, S.; Thomson, B.; McDonald, A.; Ho, P.T.; Ribrag, V. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 31LBA MOST – My Own Specific Therapy – A multicenter, randomized, open-label, phase II trial evaluating the clinical benefit of a maintenance treatment targeting tumor molecular alterations in patients with advanced solid tumors: preliminary results from the everolimus and sorafenib cohorts. (September 2015) Authors: Toulmonde, M.; Le Tourneau, C.; Cropet, C.; Italiano, A.; Bertucci, F.; Ray-Coquard, I.; Tredan, O.; Cassier, P.; Seigne, C.; De la Fouchardiere, C.; Flechon, A.; Desseigne, F.; Frappaz, D.; Gomez-Roca, C.A.; Heudel, P.E.; You, B.; Jaouen, L.; Bernardin, M.; Perol, D.; Blay, J.Y. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S725 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 324 Dose-seeking phase I trials (DSPT) of approved molecularly targeted therapies (MTT): Exhaustiveness and readability of published clinical reports. (September 2015) Authors: Cousin, S.; Hollebecque, A.; Isambert, N.; Italiano, A.; Kotecki, N.; Postel-Vinay, S.; Gobbo, J.; Toulmonde, M.; Penel, N. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 3400 Management of Desmoid Tumours (DT): A nationwide survey after labeling of 2 expert networks (RRePS and NetSarc). Issue 3 (September 2015) Authors: Penel, N.; Coindre, J.M.; Cesne, A. Le; Italiano, A.; Neuville, A.; Bonvalot, S.; Terrier, P.; Ray-Coquard, I.; Ranchere-Vince, D.; Robin, Y.M.; Isambert, N.; Chevreau, C.; Duffaud, F.; Bertucci, F.; Rios, M.; Toulmonde, M.; Péchoux, C. Le; Guillement, C.; Courréges, J.B.; Blay, J.Y. Journal: European journal of cancer Issue: Volume 51:Issue 3(2015:Feb.) Page Start: S688 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 3439 Prognostic factors in soft tissue sarcoma patients with lung metastases only receiving first-line chemotherapy. An exploratory, retrospective analysis on fifteen trials of the European Organization for Research and Treatment of Cancer - Soft Tissue and Bone Sarcoma Group (EORTC-STBSG). (September 2015) Authors: Lindner, L.; Litiere, S.; Sleijfer, S.; Judson, I.; Italiano, A.; Kasper, B.; Gelderblom, H.; Marreaud, S.; Wardelmann, E.; Gronchi, A.; Graaf, W. Van der Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S701 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 460 BIP2 (Bergonié Institute profiling program) bringing molecular profiling into routine practice in order to match molecular alterations with drugs in early phase trials. (September 2015) Authors: Toulmonde, M.; Grellety, T.; Auzanneau, C.; Laizet, Y.; Cong, K. Tran; Floquet, A.; Garbay, D.; Robert, J.; Hostein, I.; Soubeyran, I.; Italiano, A. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S98 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗